Agitation, Anesthesia, Child
Conditions
Keywords
Emergence Agitation, eye patch, preschool children
Brief summary
This study is a single-center, prospective, randomized, controlled trial. To investigate if preoperative using of eye patch will decrease emergence agitation, and to provide a better method of decreasing emergence agitation to pediatric ophthalmic anesthesiologists.
Detailed description
This study is a single-center, prospective, randomized, controlled trial. To investigate whether preoperative using of eye patches will decrease emergence agitation or not, and to provide a better method of decreasing emergence agitation to pediatric ophthalmic anesthesiologists. The investigators will recruit 180 children undergoing elective cataract surgery, divided into 2 groups by random method. experimental group will cover the effected eye for 3 hours before the operation, while the control group will not. Then the investigators will observe and mesure the incidence of emergence aditation in each group, to assess whether preoperative patch shading can reduce the incidence of postoperative agitation.
Interventions
BEHAVIORALeye patch
cover the sick eye with eye patch preoperatively for 3 hours
BEHAVIORALnon-eye patch
do not cover the sick eye with eye patch preoperatively
Sponsors
Xiaoliang Gan
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
3 Years to 7 Years
Healthy volunteers
No
Inclusion criteria
1. Preschool patients undergo elective cataract surgery, whose age are 3 to 7 years. 2. Patients' parents agree to participate in the trial, and sigh the informed consent.
Exclusion criteria
1. Patient who can not communicate with medical workers preoperatively. 2. Both of patient's eyes are covered postoperatively. 3. Patient's parents refuse to sign informed consent. 4. The investigators do not think such patient is suitable for our research 5. The patient has serious arrhythmia, abnormal cardiac defect. 6. The patient has suffered from pneumonia, asthma symptoms, bronchitis, or upper respiratory tract infection recent two weeks. 7. The patient has serious disease of the nervous system. 8. The patient has the allergic history of any drug involved in this clinical trial.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the Padiatric Anesthesia Emergence Agitation Scale | every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit. | measure patients with the pediatric anesthesia emergence agitation scale,the score more than 10 is defined as emergence agitation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| induction compliance checklist | 1 minute before general anesthesia began. | measure patients with induction compliance checklist before anesthesia. |
| heart rate (HR) | every ten minutes postoperatively, up to 1 hour. Start measuring since every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit. | measure patients' HR when patient arrived at the post operative care unit |
| respiration rate(RR) | every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit. | measure patients' RR and SpO2 when patient arrived at the post operative care unit |
| oxygen saturation(SpO2) | every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit. | measure patients' SpO2 when patient arrived at the post operative care unit |
| incidence rate of emergence agitation | every ten minutes postoperatively, up to 1 hour. Start measuring since the end of surgery until the patient back to ward from postanesthesia care unit. | calculate the number of occurrence of emergence agitation |
Countries
China
Contacts
Primary ContactXiaoliang Gan, PhD
Backup ContactYiquan Lin, MD
Outcome results
None listed